Immunization, measles (% of children ages 12-23 months)

Child immunization, measles, measures the percentage of children ages 12-23 months who received the measles vaccination before 12 months or at any time before the survey. A child is considered adequately immunized against measles after receiving one dose of vaccine. Development relevance: Immunization is one of the most cost-effective public health interventions, and ??is an essential component for reducing under-five mortality. Immunization coverage estimates are used to monitor coverage of immunization services and to guide disease eradication and elimination efforts. Limitations and exceptions: In many developing countries a lack of precise information on the size of the cohort of one-year-old children makes immunization coverage difficult to estimate from program statistics. Statistical concept and methodology: Governments in developing countries usually finance immunization against measles and diphtheria, pertussis (whooping cough), and tetanus (DTP) as part of the basic public health package. The data shown here are based on an assessment of national immunization coverage rates by the WHO and UNICEF. The assessment considered both administrative data from service providers and household survey data on children's immunization histories. Based on the data available, consideration of potential biases, and contributions of local experts, the most likely true level of immunization coverage was determined for each year. Notes on regional and global aggregates: When the vaccine is not introduced in a national immunization schedule, the missing value is assumed zero (or close to zero) in the relevant groups' averages.
Publisher
The World Bank
Origin
Global
Records
17024
Source
Immunization, measles (% of children ages 12-23 months)
country_code year value
ABW 1960
AFE 1960
AFG 1960
AFW 1960
AGO 1960
ALB 1960
AND 1960
ARB 1960
ARE 1960
ARG 1960
ARM 1960
ASM 1960
ATG 1960
AUS 1960
AUT 1960
AZE 1960
BDI 1960
BEL 1960
BEN 1960
BFA 1960
BGD 1960
BGR 1960
BHR 1960
BHS 1960
BIH 1960
BLR 1960
BLZ 1960
BMU 1960
BOL 1960
BRA 1960
BRB 1960
BRN 1960
BTN 1960
BWA 1960
CAF 1960
CAN 1960
CEB 1960
CHE 1960
CHI 1960
CHL 1960
CHN 1960
CIV 1960
CMR 1960
COD 1960
COG 1960
COL 1960
COM 1960
CPV 1960
CRI 1960
CSS 1960
CUB 1960
CUW 1960
CYM 1960
CYP 1960
CZE 1960
DEU 1960
DJI 1960
DMA 1960
DNK 1960
DOM 1960
DZA 1960
EAP 1960
EAR 1960
EAS 1960
ECA 1960
ECS 1960
ECU 1960
EGY 1960
EMU 1960
ERI 1960
ESP 1960
EST 1960
ETH 1960
EUU 1960
FCS 1960
FIN 1960
FJI 1960
FRA 1960
FRO 1960
FSM 1960
GAB 1960
GBR 1960
GEO 1960
GHA 1960
GIB 1960
GIN 1960
GMB 1960
GNB 1960
GNQ 1960
GRC 1960
GRD 1960
GRL 1960
GTM 1960
GUM 1960
GUY 1960
HIC 1960
HKG 1960
HND 1960
HPC 1960
HRV 1960

Immunization, measles (% of children ages 12-23 months)

Child immunization, measles, measures the percentage of children ages 12-23 months who received the measles vaccination before 12 months or at any time before the survey. A child is considered adequately immunized against measles after receiving one dose of vaccine. Development relevance: Immunization is one of the most cost-effective public health interventions, and ??is an essential component for reducing under-five mortality. Immunization coverage estimates are used to monitor coverage of immunization services and to guide disease eradication and elimination efforts. Limitations and exceptions: In many developing countries a lack of precise information on the size of the cohort of one-year-old children makes immunization coverage difficult to estimate from program statistics. Statistical concept and methodology: Governments in developing countries usually finance immunization against measles and diphtheria, pertussis (whooping cough), and tetanus (DTP) as part of the basic public health package. The data shown here are based on an assessment of national immunization coverage rates by the WHO and UNICEF. The assessment considered both administrative data from service providers and household survey data on children's immunization histories. Based on the data available, consideration of potential biases, and contributions of local experts, the most likely true level of immunization coverage was determined for each year. Notes on regional and global aggregates: When the vaccine is not introduced in a national immunization schedule, the missing value is assumed zero (or close to zero) in the relevant groups' averages.
Publisher
The World Bank
Origin
Global
Records
17024
Source